Inactief instrument

Andere talen Vitality Biopharma Inc OTC Bulletin Board

Aandelen

STVF

US86031Q1040

slotkoers OTC Bulletin Board Andere beurzen
- ^USD	-

26/04	Range Impact, Inc. Kondigt Executive Wijzigingen aan	CI
29/03	Range Impact, Inc. Rapporteert winstresultaten voor het vierde kwartaal dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Range Impact Transitions Two Executives to Graphium Biosciences Subsidiary as Part of Proposed Divestiture and Promotes Corporate Controller to Chief Financial Officer	26/04
Range Impact, Inc. Announces Executive Changes	26/04
Range Impact, Inc. Announces Chief Financial Officer Changes	26/04
Range Impact, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	29/03
Range Impact, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
Range Impact Reports 4Q 2023 and Full Year 2023 Financial Results	29/03
Range Impact, Inc. Announces Executive Appointments	30/01
Range Impact Announces Former Ohio Congressman Zack Space and Former Ohio Senator Jay Hottinger Have Joined the Company as Strategic Advisors	29/01
Range Impact Announces $1.7 Million Capital Raise Led by Strategic Investors	21/12
Range Impact, Inc. announced that it has received $1.7 million in funding	21/12
Malachite Innovations Changes its Name to Range Impact and Adopts New Ticker Symbol “RNGE”	14/12
Malachite Innovations, Inc. has Changed its Name to Range Impact, Inc	14/12
Malachite Innovations, Inc. has Changed its Ticker to RNGE from MLCT	14/12
Malachite Innovations Retains Investment Banking Firm to Assist in Implementation of Strategic Plan for Cannabinoid Drug Development Business	07/12
Graphium Biosciences, Inc. announced that it expects to receive $4 million in funding from Range Impact, Inc.	07/12
Earnings Flash (MLCT) MALACHITE INNOVATIONS Reports Q3 Revenue $5.5M	14/11
Malachite Innovations, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
MALACHITE INNOVATIONS REPORTS THIRD QUARTER 2023 RESULTS	14/11
(MLCT) MALACHITE INNOVATIONS Expects Q4 Revenue $5.5M	14/11
MALACHITE INNOVATIONS ANNOUNCES CLOSING OF $1.0 MILLION CAPITAL RAISE TO FUND FIRST ACQUISITION OF FORMER MINE LAND	15-09-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Vitality Biopharma Inc OTC Bulletin Board

Aandelen

STVF

US86031Q1040

Andere talen

Filters